한국어
English
日本語
中文(简体)
Cabometyx 60 mg (Cabozantinib)
76.03mg
Tablet · Prescription medication
Ipsen Korea Co., Ltd.
Cabozantinib (S)-malate is an anticancer agent that inhibits the growth of malignant tumors.
MFDS ingredient code M266850
Cabozantinib (S)-malate is a targeted anticancer agent used in the treatment of various types of cancer. It works by blocking the activity of specific proteins, thereby inhibiting the proliferation and metastasis of cancer cells. It primarily exhibits anticancer effects in renal cancer, thyroid cancer, and more.
Cabozantinib (S)-malate blocks signaling pathways that promote angiogenesis around cancer cells. This reduces the nutrient supply to the tumor tissues, preventing tumor growth and spread. Additionally, it also suppresses the proliferation signals of the cancer cells themselves, exerting anticancer effects.
Approved uses differ by product. Check each product's information for its actual use.
Cabozantinib is a multi-kinase inhibitor that inhibits multiple target proteins simultaneously. As a result, it shows a broader suppressive effect on cancer cell growth compared to single-target therapies. The malate form helps enhance the stability and absorption of the drug.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
